RE: NASDAQ19 May 2022 08:24
Although I'm aware that Duncan et al have invested a significant amount in DDDD, that was some time ago. They have opportunity to buy in now at a much lower price than the options they awarded themselves in order to demonstrate to shareholders their confidence in the company. Even a relatively small buy would begin to help to restore that confidence. Its possible, if a sale is being negotiated and I appreciate that's speculation, though personally think it likely, then they may perhaps not be able to buy at present. Lets hope the next RNS is Oxford update, BoD buy in or sale. Even extremely positive results don't seem to be moving the needle, which is frustrating.